1 year return (CAGR)
-13.70%
Alterity Therapeutics Ltd Exchange (NASDAQ, USD)
ATHE
3.78
-0.13 (-3.32%)
HealthcareBiotechnology
Loading...
3 year return (CAGR)
11.66%
5 year return (CAGR)
-22.13%
10 year return (CAGR)
-23.31%
Objective Corporation Stock Analysis – State Within State
Read MoreMarketcap
68.83M
Price/Sales
17.96
Ent value
34.80M
Price/Book
1.61
Div yield
0.00%
Growth years
-
Div growth
-
FCF payout
0.00%
Trailing P/E
-
PEG
-
Forward P/E
-
EPS growth
-24.76%
Stock information
What is a stock exchange? Operation, actors, examples
Read MoreStock chart
Loading...
Stock price data
| Open | 3.90 |
| Daily high | 3.90 |
| Daily low | 3.65 |
| Daily Volume | 11K |
| All-time high | 765.00 |
| 1y analyst estimate | 13.25 |
| Beta | -0.04 |
| EPS (TTM) | -1.57 |
| Dividend per share | 0.00 |
| Ex-div date | - |
| Next earnings date | - |
Downside potential
Loading...
Downside potential data
| ATHE | S&P500 | |
| Current price drop from All-time high | -99.51% | -0.56% |
| Highest price drop | -99.86% | -56.47% |
| Date of highest drop | 25 Nov 2024 | 9 Mar 2009 |
| Avg drop from high | -87.38% | -10.68% |
| Avg time to new high | 1180 days | 12 days |
| Max time to new high | 5894 days | 1805 days |
News
